HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of natural killer cell monoclonal expansion during efalizumab treatment in a patient with psoriasis.

AuthorsM Caproni, W Volpi, C Chiarini, E Antiga, B Giomi, P Fabbri
JournalThe British journal of dermatology (Br J Dermatol) Vol. 160 Issue 4 Pg. 896-7 (Apr 2009) ISSN: 1365-2133 [Electronic] England
PMID19239461 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • efalizumab
Topics
  • Aged
  • Antibodies, Monoclonal (adverse effects, metabolism, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Immunosuppressive Agents (adverse effects, therapeutic use)
  • Killer Cells, Natural (drug effects)
  • Lymphocytosis (chemically induced)
  • Male
  • Psoriasis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: